Geneos Wealth Management’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,900
Closed -$4K 2828
2022
Q1
$4K Hold
2,900
﹤0.01% 2437
2021
Q4
$9K Buy
+2,900
New +$16.3K ﹤0.01% 2244

Other funds holding AFIB

Geneos Wealth Management's AFIB Position: Q2 2022 in Review

Geneos Wealth Management sold out of Acutus Medical Inc (AFIB) in Q2 2022, closing a stake of 2,900 shares — an estimated $4K sold.

Geneos Wealth Management first reported a position in AFIB in Q4 2021 and held it in 2 quarters. The position peaked at $9K in Q4 2021. 47 funds tracked by Wall St. Rank hold AFIB as of Q2 2022.

  • Geneos Wealth Management reported no remaining Acutus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 2,900 Acutus Medical Inc shares in Q2 2022, an estimated $4K.
  • Geneos Wealth Management first reported a position in Acutus Medical Inc in Q4 2021 and held it in 2 quarters.
  • Geneos Wealth Management's Acutus Medical Inc position peaked at $9K in Q4 2021.
  • 47 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2022.

Based on Geneos Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.